Multiple psychotropic medication use for youths: A two-state comparison

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 1, 2005, Pages 68-77

  Dosreis, Susan ^a,b   Zito, Julie M ^c   Safer, Daniel J ^a   Gardner, James F ^c   Puccia, Karen B ^a   Owens, Pamela L ^b,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPNOTIC SEDATIVE AGENT; LITHIUM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG USE; FEMALE; FOSTER CARE; HEALTH INSURANCE; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL HEALTH SERVICE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INSURANCE, HEALTH; MALE; MEDICAID; PSYCHOTROPIC DRUGS; STATE HEALTH PLANS; UNITED STATES;

EID: 14944356398     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.68     Document Type: Article

References (20)

1. American Medical Association: International Classification of Disease, 9th revision. American Medical Association, 2000.
2. Barkley, RA: Attention-Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment. New York: The Guilford Press, 1998.
3. Bhatara VS, Fell M, Hoagwood K, Vitiello B, Zima B: Trends in combined pharmacotherapy with stimulants for children. Psychiatr Serv 53(3):244, 2002.
4. Connor DF, Ozbayrak KR, Kusiak KA, Caponi AB, Melloni RH: Combined pharmacotherapy in children and adolescents in a residential treatment center. J Am Acad Child Adolesc Psychiatry 36(2): 248-254, 1997.
5. Efron D, Hiscock H, Sewell JR, Cranswick NE, Vance ALA, Tyl Y, Luk ES: Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 111(2):372-375, 2003.
6. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conner CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B: ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40(2):147-158, 2001.
7. Martin A, Sherwin T, Stubbe D, Van Hoof T, Scahill L, Leslie D: Use of multiple psychotropic drugs by Medicaid-insured and privately insured children. Psychiatr Serv, 53(12):1508, 2002.
8. Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L: Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 54(1): 72-77, 2003.
9. Olfson M, Marcus S, Weissman MM, Jensen PS: National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 41(5):514-521, 2002.
10. Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC: Patterns of psychotropic medication use in very young children with attention deficit hyperactivity disorder. J Dev Behav Pediatr 23(1):23-30, 2002.
11. Richardson LP, DiGiuseppe D, Christakis DA, McCauley E, Katon W: Quality of care for Medicaid-covered youth treated with antidepressant therapy. Arch Gen Psychiatry 61(5):475-480, 2004.
12. Rushton JL, Whitmire JT: Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends. Arch Pediatr Adolesc Med 155: 560-565, 2001.
13. Safer DJ, Zito JM, dosReis S: Concomitant psychotropic medication for youths. Am J Psychiatry 160(3):438-449, 2003.
14. Schirm E, Tobi H, Zito JM, de Jon-Van den Berg LTW: Psychotropic medication in children: A study from the Netherlands. Pediatrics 108(2): e25, 2001.
15. Shireman TI, Olson BM, Dewan NA: Patterns of antidepressant use among children and adolescents. Psychiatr Serv 53(11):1444-1450, 2002.
16. Warner LA, Pottick KJ, Mukherjee A: Use of psychotropic medications by youths with psychiatric diagnoses in the U.S. mental health system. Psychiatr Serv 55(3):309-311, 2004.
17. Zarin DA, Suarez AP, Pincus HA, Kupersanin E, Zito JM: Clinical and treatment characteristics of children with attention deficit hyperactivity disorder in psychiatric practice. J Am Acad Child Adolesc Psychiatry 37(12):1262-1270, 1998.
18. Zima BT, Bussing R, Crecelius GM, Kaufman A, Belin TR: Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. Am J Public Health 89(11): 1732-1735, 1999.
19. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth. A 10-year perspective. Arch Pediatr Adolesc Med 157:17-25, 2003.
20. Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA: Psychotherapeutic medication patterns for youths with attention deficit hyperactivity disorder. Arch Pediatr Adolesc Med 153:1257-1263, 1999.